Document is current

Article History

Received: 20 July 2020

Accepted: 25 August 2020

First Online: 5 September 2020

Ethics approval and consent to participate

: We have respected the ethical standards of our institution. However, in the context of intensive care and COVID-19 no written consent has been obtained. The patient was immediately intubated and then placed on ECMO. In this context, we were unable to obtain his written consent. Moreover, during the confinement period, no family visits were allowed to the hospital. Even if the family was informed of the patient’s progress and of his therapeutic management, no written consent was required.<i>Reference: Tim C. Jansen, Jan Bakker, and Erwin J. O. Kompanje.</i><b><i>Inability to obtain deferred consent due to early death in emergency research: effect on validity of clinical trial results.</i></b><i>Intensive Care Med. 2010 Nov; 36(11): 1962–1965. Intensive Care Med. 2010 Nov; 36(11): 1962–1965. Published online 2010 Aug 6. doi:</i>ExternalRef removed

: The publication is completely anonymous and this document in this particular context will not add to the scientific value of this article. We also believe that there will be no added ethical value and we don't want to confront relatives to an additional emotional burden.

: Not applicable.